Literature DB >> 17218915

Long-term outcomes of vitrectomy with or without arteriovenous sheathotomy in branch retinal vein occlusion.

Kazuyuki Kumagai1, Mariko Furukawa, Nobuchika Ogino, Akinori Uemura, Eric Larson.   

Abstract

PURPOSE: To evaluate the long-term effect of vitrectomy with or without arteriovenous sheathotomy for macular edema secondary to branch retinal vein occlusion (BRVO).
METHODS: The study was a prospective, randomized, comparative, interventional case series of 36 patients (36 eyes) who underwent pars plana vitrectomy with or without arteriovenous sheathotomy for macular edema due to BRVO of <or=8 weeks' duration of symptoms. Eighteen eyes with arteriovenous sheathotomy (sheathotomy group) were compared with 18 eyes without sheathotomy (vitrectomy group). Main outcomes measures were best-corrected visual acuity and central foveal thickness as evaluated by optical coherence tomography.
RESULTS: Baseline demographic characteristics of the groups were similar. Postoperative follow-up period ranged from 12 months to 45 months (31 months). Median best-corrected visual acuity significantly improved from 0.4 at baseline to 1.0 at the final visit in both groups, and there was no significant difference in best-corrected visual acuity at any postoperative period between the groups. Of 16 patients with duration of symptoms of <4 weeks, those with arteriovenous sheathotomy had a tendency toward better visual outcomes than those without arteriovenous sheathotomy (P = 0.064). The central foveal thickness also significantly decreased after surgery in both groups, but the differences were not significant for the two groups at each time point. No patients had severe intraoperative and/or postoperative complications.
CONCLUSIONS: Our findings suggest that vitrectomy with or without arteriovenous sheathotomy may improve the long-term functional and tomographic outcomes for patients with macular edema secondary to BRVO. Although additional arteriovenous sheathotomy did not lead to a distinct functional benefit in this series, early surgical intervention may result in better visual outcomes.

Entities:  

Mesh:

Year:  2007        PMID: 17218915     DOI: 10.1097/01.iae.0000221996.77421.69

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  34 in total

1.  Prospective multicenter study of visual outcomes following three different treatments for macular edema associated with branch retinal vein occlusion: a study by the Japanese BRVO study group.

Authors:  Seiyo Harino; Kenichiro Bessho; Teruyo Kida
Journal:  Jpn J Ophthalmol       Date:  2012-02-23       Impact factor: 2.447

Review 2.  [Arteriovenous dissection for branch retinal vein occlusion].

Authors:  N Feltgen; L-O Hattenbach; A Mirshahi; L Hansen
Journal:  Ophthalmologe       Date:  2008-04       Impact factor: 1.059

3.  Visual acuity and multifocal electroretinographic changes after arteriovenous crossing sheathotomy for macular edema associated with branch retinal vein occlusion.

Authors:  Eun Jee Chung; William R Freeman; Hyoung Jun Koh
Journal:  Retina       Date:  2008-02       Impact factor: 4.256

4.  Arteriovenous crossing sheathotomy versus intravitreal triamcinolone acetonide injection for treatment of macular edema associated with branch retinal vein occlusion.

Authors:  Eun Jee Chung; Hyo Lee; Hyoung Jun Koh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-04-19       Impact factor: 3.117

5.  Association of electroretinogram and morphological findings in branch retinal vein occlusion with macular edema.

Authors:  Hidetaka Noma; Hideharu Funatsu; Seiyo Harino; Takeshi Sugawara; Tatsuya Mimura; Katsunori Shimada
Journal:  Doc Ophthalmol       Date:  2011-07-30       Impact factor: 2.379

6.  Structural and functional assessment after intravitreal injection of ranibizumab in diabetic macular edema.

Authors:  YuDong Fu; Ping Wang; XuXia Meng; Zhaodong Du; DaBo Wang
Journal:  Doc Ophthalmol       Date:  2017-07-29       Impact factor: 2.379

7.  Treatment of macular edema due to branch retinal vein occlusion with single or multiple intravitreal injections of bevacizumab.

Authors:  Tatsuya Yunoki; Akio Miyakoshi; Tomoko Nakamura; Kazuya Fujita; Chiharu Fuchizawa; Atsushi Hayashi
Journal:  Jpn J Ophthalmol       Date:  2012-01-14       Impact factor: 2.447

8.  Influence of retinal ischemia on macular function after pars plana vitrectomy for macular edema with branch retinal vein occlusion.

Authors:  Hidetaka Noma; Katsunori Shimada; Tatsuya Mimura
Journal:  Int Ophthalmol       Date:  2013-03-29       Impact factor: 2.031

9.  Intravitreous bevacizumab in the treatment of macular edema from branch retinal vein occlusion and hemisphere retinal vein occlusion (an AOS thesis).

Authors:  Gary Edd Fish
Journal:  Trans Am Ophthalmol Soc       Date:  2008

10.  Evaluation of ultrasound-assisted thrombolysis using custom liposomes in a model of retinal vein occlusion.

Authors:  Walid F Abdallah; Hitenkumar Patel; Edward G Grant; Bruno Diniz; Gerald J Chader; Mark S Humayun
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-10-05       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.